MiR-374a-5p was able to target arrestin beta 1 (ARRB1) that was downregulated in TNBC patients and the ARRB1 expression was inversely correlated with the histological grade of breast cancer and correlated with the survival of TNBC patients [185]. The gene discussed is ARRB1; the disease is breast cancer.